Never invest by absolute rules. Many OTC stocks become winners. NEOP was listed on Nasdaq and maintained all SEC filings per Nasdaq requirements in preparation for relisting.

Biotechs like DNDN, VNDA and NEOP live on FDA drug progress. One successful trial can push them up 1,000% higher in one trading session. NEOP has two drugs in Phase 3 FDA trials. Most small biotechs only have one.

I bought 210K NEOP at .25 when people like you said never invest in OTC stocks. It's already $1.25 and the first Phase 3 trial doesnt even finish until later this year.

If you had said never invest in pink sheet stocks I would agree. But pinkies and OTC are quite different.